The effect of ethanol on N-demethylation of aminopyrine in rat liver slices andcin the microsomal fraction and on microsomal hydroxylation of pentobarbital and aniline was studied. With liver slices N-demethylation of aminopyrine was stimulated by 35-40% at low ethanol concentrations (2mM), whereas no stimulation occurred at high concentrations (100mM). With the liver microsomal fraction, an inhibitory effect was observed only at high ethanol concentrations (100mM). This was also observed with the other drugs studied. In agreement with these results, only at a high concentration did ethanol interfere with the binding of drug substrates to cytochrome P-450. Further, as previously reported, ethanol produced a reverse type I spectral change when added to the liver microsomal fraction. Evidence that this spectral change is due to removal of substrate, endogenously bound to cytochrome P-450, is reported. A dual effect of ethanol is assumed to explain the present findings; in liver slices, at a low ethanol concentration, the enhanced rate of drug oxidation is the result of an increased NADH concentration, whereas the inhibitory effect observed with the microsomal fraction at high ethanol concentration is due to the interference by ethanol with the binding of drug substrates to cytochrome P450.
The effect of ethanol on N-demethylation of aminopyrine in rat liver slices andcin the microsomal fraction and on microsomal hydroxylation of pentobarbital and aniline was studied. With liver slices N-demethylation of aminopyrine was stimulated by 35-40% at low ethanol concentrations (2mM), whereas no stimulation occurred at high concentrations (100mM). With the liver microsomal fraction, an inhibitory effect was observed only at high ethanol concentrations (100mM). This was also observed with the other drugs studied. In agreement with these results, only at a high concentration did ethanol interfere with the binding of drug substrates to cytochrome P-450. Further, as previously reported, ethanol produced a reverse type I spectral change when added to the liver microsomal fraction. Evidence that this spectral change is due to removal of substrate, endogenously bound to cytochrome P-450, is reported. A dual effect of ethanol is assumed to explain the present findings; in liver slices, at a low ethanol concentration, the enhanced rate of drug oxidation is the result of an increased NADH concentration, whereas the inhibitory effect observed with the microsomal fraction at high ethanol concentration is due to the interference by ethanol with the binding of drug substrates to cytochrome P450. Orme-Johnson & Ziegler (1965) reported the oxidation of both methanol and ethanol in vitro by hepatic microsomal fraction in the presence of NADPH and molecular 02. The oxidation of ethanol to acetaldehyde by the microsomal fraction was confirmed and extended by Lieber & DeCarli (1968) who, in contrast to Orme-Johnson & Ziegler (1965) , observed inhibition (60-70 %.) of microsomal ethanol metabolism by CO. The requirement for NADPH and 02 and the sensitivity to CO are also characteristic of the microsomal cytochrome P450-containing monooxygenase system. Further, the experimental administration of ethanol to human volunteers, both alcoholics and non-alcoholics, and to male rats resulted in a proliferation of the smooth endoplasmic reticulum of the hepatocytes (Iseri et al., 1966; Lane & Lieber, 1966) , a finding similar to that produced by many drugs (see Conney, 1967 , for review). These observations led Lieber & DeCarli (1968) to postulate the presence of an ethanol-oxidizing system in the microsomal fraction which is distinct from hepatic alcohol dehydrogenase, an enzyme present in the soluble fraction (see Jacobsen, 1952, for review) . Rubin et al. (1970) reported that microsomal ethanol-oxidizing-system activity is significantly inhibited by drug substrates of the mono-oxygenase system and in addition that ethanol inhibits the hydroxylation of pentobarbital and aniline in vitro by the * Present address: Department of Pharmacology, University of Connecticut Health Center, Farmington, Conn. 06032, U.S.A.
Vol. 134 microsomal fraction; with aniline hydroxylation, the inhibition was shown to be competitive . These findings suggested that the microsomal metabolism of various drugs and ethanol involves common enzyme components. Further, the addition of high concentrations of ethanol to a microsomal suspension induced a reverse type I (modified type II) spectral change (Schenkman et al., 1967) , suggesting an interaction between cytochrome P450 and ethanol (Rubin et al., 1971) .
However, based on other investigations, not only the role of the microsomal ethanol-oxidizing system in vivo but also its actual existence have been questioned. For example, inhibitors and inducers of the hepatic microsomal mono-oxygenase system did not affect metabolism of ethanol in vivo (Klaassen, 1969; Tephly etal., 1969; Khanna & Kalant, 1970; Khanna et al., 1972) . Moreover, Hassinen & Ylikahri (1972) , using isolated perfused livers from normal and phenobarbital-treated rats, reported that addition ofethanol to the perfusion medium did not cause any redox changes of cytochrome P450, concluding that the role of the microsomal ethanol-oxidizing system in ethanol oxidation in intact liver is insignificant. Aminotriazole, an inhibitor of the biosynthesis of catalase (Tschudy & Collins, 1959) was found to decrease the microsomal production of acetaldehyde from ethanol when added in vitro or when injected in vivo (Roach et al., 1969; Isselbacher & Carter, 1970) , implicating catalase in the oxidation of ethanol. Thurman et al. (1972) presented strong evidence that the microsomal ethanol-oxidizing system is due to contaminating catalase plus H202 generated by microsomal NADPH oxidase in the presence of NADPH and 02 (Gillette et al., 1957) . If the microsomal ethanol-oxidizing system is indeed a non-entity as suggested by the results of Thurman et al. (1972) (Taby, Sweden) , and fed on a standard laboratory diet. Livers were removed and treated as described previously . The slices (approx. 0.5mm thick) were prepared by using a Stadie-Riggs microtome. Livers were homogenized in Svol. of cold 0.25M-sucrose with a glassTeflon homogenizer and microsomal fractions were prepared either by differential ultracentrifugation as described by Ernster et al. (1962) or by the Ca2+ sedimentation procedure as described by . Identical results were obtained with either method of preparation of the microsomal fraction. Protein concentrations were determined by the method of Lowry et al. (1951) .
The rate of demethylation of aminopyrine in the presence and absence of4-methylpyrazole and ethanol was measured in a system containing 50mM-Tris-HCI buffer, pH7.5, 5mM-MgCI2, 1mM-NADP+, 5mM-DL-isocitrate and 0.4 unit of pig heart isocitrate dehydrogenase, in a final volume of 2ml. When present, the final concentration of 4-methylpyrazole was 2mM. The concentrations ofaminopyrine and ethanol used varied with each experiment and are indicated in the figure legends or the tables. The reaction was started by addition of either microsomal fraction (1.Omg of protein/ml) or liver slices (200-250mg). Incubations were performed in a Dubnoff shaker for 10min at 37°C in an atmosphere ofair. Formaldehyde formed was measured by the procedure of Nash (1953) .
The hydroxylation of aniline was measured with the same incubation medium used for aminopyrine N-demethylation. The reaction was started with 1.5mg of microsomal protein/ml. The incubation time in the Dubnoff shaker was 20min at 37°C in air. Aniline hydroxylase activity was determined by measuring the formation of p-aminophenol (Schenkman et al., 1967) .
For the determination of pentobarbital metabolism, incubations were performed as for aniline, but with 0.1mm-sodium pentobarbital and 1.5mg of microsomal protein per incubation mixture. At the end of 20min, the reaction was stopped by freezing the tubes in a solid C02-ethanol mixture; 0.5g of NaCl and known concentrations of aprobarbital were then added to each tube and the mixture was extracted with 10ml of chloroform by shaking for Smin. After centrifugation to separate the phases, the chloroform phase was evaporated and the residue dissolved in 0.5-1 ml ofchloroform, ofwhich portions (0.5-1 Iu) were injected into a gas chromatograph. G.l.c. was performed with a Varian 1440 gas chromatograph equipped with a H2 flame ionization detector. Flash heater and detector were kept at 240°C and column oven at 210°C. N2 at 30ml/min was used as the carrier gas. The silicone-treated coiled glass columns (2m x 2mminternaldiam.)were packed with 3 % Hi-EFF-3A (neopentyl glycol adipate) on Gas-chrom Q. The peak areas were measured by cutting and weighing the chromatograms, and pentobarbital concentrations were calculated by using aprobarbital as an internal standard.
Cytochrome P-450 was measured with an AmincoChance split-beam dual-wavelength recording spectrophotometer as described by Omura & Sato (1964) by using the extinction coefficient of 91 mM-Icm1.
Spectral changes produced by addition of substances to suspensions ofliver microsomal fractions were also recorded with the same spectrophotometer. Spectral dissociation constants (K.) were obtained from double-reciprocal plots (Schenkman, 1970) .
Washing of the microsomal fraction was performed as follows. Microsomal fractions were resuspended in 0.15M-KCI to a final concentration of 10-15mg of protein/ml; a sample was removed for measurement of cytochrome P-450 and for titration of the spectral changes with hexobarbital and ethanol. To the remaining microsomal suspension was added 0.15M-1973 KC1 containing 100mM-ethanol (final concn.). The mixture was gently stirred for 2min at 4°C, followed by centrifugation at 105000g for 45 min (Ca2+-sedimented microsomal fractions were centrifuged at 20000g for 10min); the pellets were then washed three times with lOvol. of 0.15M-KCI to remove the ethanol, resuspended in 0.15M-KCI to a final protein concentration of 10-15 mg/ml and a sample was taken for cytochrome P-450 measurement and titration of hexobarbital-and ethanol-produced spectral changes (washed fraction 1). The remaining microsomal suspension was washed again as described above, yielding washed fraction 2. The control microsomal fractions were also washed twice with 0.15M-KCI containing no ethanol.
Kinetic plots were determined by linear regression analyses; all correlation coefficients were greater than 0.9.
Results
Effect ofethanol on N-demethylation ofaminopyrine in liver slices and microsomal fractions
In the light of the discrepancies mentioned in the introduction we studied the effect of various concentrations of ethanol on the N-demethylation of aminopyrine in both liver slices and the microsomal fraction.
As shown in Table 1 , 2mM-and 20mM-ethanol increased the rate ofN-demethylation ofaminopyrine in rat liver slices by about 35-40 %. However, at a much higher ethanol concentration the stimulation was completely abolished (503 compared with 493 nmol of formaldehyde/lOmin per g of liver), suggesting a dual or more complex effect of ethanol. To determine whether the observed increase in oxidation of aminopyrine was due, at least in part, to an increased concentration of NADH resulting from the metabolism ofethanol, 2mM-4-methylpyrazole, a potent inhibitor of alcohol dehydrogenase (Theorell et al., 1969) , was added to the incubation medium ( Table 2 ). The presence of 4-methylpyrazole alone did not affect the rate of N-demethylation of aminopyrine (493 compared with 498nmol of formaldehyde/lOmin per g of liver). However, in the presence of 2mM-ethanol the 35-40% increase in demethylation was diminished by 50% (669 compared with 595 nmol of formaldehyde/lOmin per g of liver), although the rate was still significantly higher than that observed in the controls. At higher concentrations of ethanol, the observed increase was removed, and in fact a 15-20 % decrease in the rate of N-demethylation was often observed. It thus appears that at least two ethanol effects exist: (1) the oxidation of ethanol by alcohol dehydrogenase resulting in an increased NADH/ Table 1 . Rate ofaminopyrine N-demethylation in liver slices in thepresence ofvarious concentrations ofethanol The concentration ofaminopyrine in the incubation medium was 8.0mM; the reaction was initiated by the addition of the liver slices. Values for demethylation are means ± S.E.M. with number of observations in parentheses, and P values are a comparison between the presence and absence of ethanol. N.S., not significant.
Aminopyrine N-demethylation (nmol of formaldehyde/lOmin per g of liver)
493 ± 29 (29) 669± 90 (10) 664±72 (10) 503 ± 66 (10) NAD+ ratio, which could conceivably support drug metabolism, and (2) an inhibitory effect by high ethanol concentrations on the microsomal mono-oxygenase system, directly or indirectly via a non-specific effect on the membrane. In contrast to the oxidation rate in liver slices, microsomal N-demethylation of aminopyrine was not affected by ethanol when the concentrations in the incubation medium ranged between 1 and 50mM; an inhibitory effect, possibly competitive, was observed, however, with 100mm-ethanol (Fig. 1) .
The lack of stimulation of aminopyrine N-demethylation by the microsomal fraction in the presence oflow concentrations of ethanol was not unexpected, however, since microsomal oxidation ofethanol, if indeed any occurred, would not result in the generation of NADH.
To be certain that our observations were real and not artifacts attributed to interference by acetaldehyde, which is a product of ethanol oxidation, increasing concentrations of acetaldehyde ranging from 10P-M to 10mM were added to the incubation medium during analysis of aminopyrine demethylation in both liver slices and microsomal fractions. The amount of formaldehyde formed remained constant in the presence of increasing concentrations of acetaldehyde.
Effect of ethanol on pentobarbital metabolism by rat liver microsomalfraction
Contrary to a previous report , pentobarbital hydroxylation by the microsomal fraction was not significantly affected by ethanol concentrations in the range 2-50mM (Fig. 2) ; at 100mM-ethanol, however, there was a decrease, an effect similar to that observed with aminopyrine.
Effect of ethanol on aniline hydroxylation by rat liver microsomalfraction Rubin et al. (1970) reported that in the presence of 3 mM-and 8 mM-ethanol, microsomal aniline hydroxy- It is well known that the addition of hexobarbital to a microsomal suspension results in a type I spectral change, the magnitude of which is proportional to the amount ofhaemoprotein available for interaction with the substrate (Schenkman et al., 1967) . As shown in Fig. 4 , the presence of ethanol in both cuvettes caused a decrease in the magnitude of the hexobarbital-induced type I spectral change. The spectral dissociation constant (Ks) tended to increase (from 0.11 to 0.15mM), suggesting a competitive type of inhibition, but only in the presence of high concentrations of ethanol.
In the presence of hexobarbital in the sample cuvette containing a microsomal suspension, addition of 100mM-ethanol to the reference cuvette resulted in a greater hexobarbital-induced type I spectral change (Fig. 5, curves A and B) . When ethanol was present in Fig. 2 (Fig. 4, and Fig. 5, curve C) . Addition of ethanol to a microsomal suspension resulted in a reverse type I spectral change (Fig. 5, curve D) as reported by Rubin et al. (1971) . Further, adding hexobarbital to both cuvettes increased the magnitude of the ethanolinduced reverse type I spectral change (Fig. 5 , curve E). These effects can be explained in two ways. (1) Ethanol physically binds to the apoprotein of cytochrome P-450 and in doing so produces the reverse type I spectral change. This would explain the increase in the magnitude of the hexobarbital-induced type I spectral change on addition of ethanol to the reference cuvette, which would be due to an algebraic summation of the type I spectral change in the sample cuvette and the reverse type I spectral change in the reference cuvette (curve B). The decrease in the hexobarbital-produced type I spectral change when ethanol was present in both cuvettes (curve C) and the increase in the ethanol-induced reverse type I spectral change when hexobarbital was present in both cuvettes (curve E) could in turn be due to a type I component ofethanol binding (cf. Schenkman, 1970) .
(2) Ethanol does not bind to cytochrome P-450 but induces a reverse type I spectral change by its ability to remove endogenously bound substrate from cytochrome P450; this would adequately explain curves B, C, D and E in Fig. 5 .
Effect ofethanol washing ofthe microsomalfraction on the hexobarbital-and ethanol-induced spectral changes To separate these two apparently valid explanations of the ethanol effect, microsomal fractions were washed with 100mM-ethanol, based on the belief that if indeed ethanol was removing endogenously bound substrate, washing with ethanol would release substrate from cytochrome P450, making more haemoprotein available for interaction with hexobarbital; in addition the magnitude of the ethanolinduced reverse type I spectral change would be decreased. If, however, ethanol did bind to cytochrome P-450, then washing of microsomal fraction would not affect either the type I or reverse type I spectral change. As shown in Fig. 6(a) microsomal fraction washed twice with 100mM-ethanol (see the Materials and Methods section) produced a greater type I spectral change on addition of increasing concentrations of hexobarbital; further, the reverse type I spectral change induced by ethanol was diminished (Fig. 6b) . To substantiate the ethanol effect, microsomal fractions were washed twice with 0.15M-KCI only; these washed microsomal fractions produced hexobarbital-and ethanol-induced spectral changes identical with those observed with control microsomal fraction. Moreover, to ensure that washed microsomal fractions did not contain residual Wavelength (nm) Fig. 5 . Optical difference spectra ofsubstrate binding to rat liver microsomalfraction A microsomal suspension containing 1.6mg of protein/ml in 0.05 M-Tris-HCl buffer, pH7.5, was divided equally between two cuvettes. Curve A, 0.33mM-hexobarbital (final concn.) was added to sample cuvette and a corresponding volume of buffer was added to the reference cuvette; curve B, 100mM-ethanol was added to the reference cuvette (18,ul of ethanol); curve C, new microsomal suspension also containing 1.6mg of protein/ml and 240mm-ethanol was divided between two cuvettes and 0.33mM-hexobarbital was added to the sample cuvette; curve D, addition of 250mM-ethanol to the sample cuvette containing 2.0mg of microsomal protein/ml, followed by addition of 0.5 mm-hexobarbital to both cuvettes (curve E). For Fig. 5 , curve C).
Discussion
Whereas the role of the microsomal cytochrome-P-450-containing mono-oxygenase system in liver has recently been questioned with regard to its involvement in the oxidation of ethanol both in vivo and in vitro, there is general agreement that various drug oxidations are affected by high concentrations ofethanol. Based on our observations with liver slices and microsomal fractions, we propose at least two diametrically opposed effects of ethanol; at low concentrations of ethanol, drug oxidation is stimulated, possibly by an increase in the cytoplasmic NADH/ NAD+ ratio resulting from alcohol dehydrogenasedependent oxidation of ethanol; Rawat (1972) has shown that rat liver slices utilize more than 40,umol of ethanol/h per g wet wt. of liver, which results in the production of a stoicheiometrically equivalent amount of NADH. Since Cohen & Estabrook (1971) , Hildebrandt & have shown that drug oxidations are enhanced in the presence of both NADPH and NADH, the increased NADH/NAD+ ratio would explain such a stimulatory effect of ethanol in liver slices, where the concentration of reduced nicotinamide nucleotides may be more critical for optimum drug oxidation rates than in vivo. That the stimulatory effect of ethanol was in fact due to NADH production is strongly suggested by our experiments with 4-methylpyrazole. Moreover, this effect was not obtained with microsomal fractions, which was expected since alcohol dehydrogenase is present only in the soluble fractions.
At high ethanol concentrations (100mM or greater), however, an inhibitory effect on drug oxidation was observed. This inhibition has been attributed to a direct effect by ethanol on the mono-oxygenase system by interacting with the terminal oxidase, cytochrome P450 (Imai & Sato, 1967; Rubin et al., 1971) . Evidence for this assertion has been based on (a) inhibition ofmicrosomal ethanol-oxidizing system activity by CO, (b) the reverse type I spectral change obtained when ethanol is added to a liver microsomal suspension, (c) inhibition of microsomal ethanol-oxidizing system activity by drugs, and (d) inhibition in vitro of pentobarbital and aniline hydroxylase activities by ethanol. Our studies also showed inhibition in vitro of microsomal aminopyrine Ndemethylation, but only when high ethanol concentrations were used (see Fig. 1 ). Similarly, pentobarbital metabolism was inhibited only in the presence of high concentrations of ethanol. Moreover, contrary to the report of Rubin et al. (1970) , who found a competitive inhibition of aniline hydroxylase activity in the presence of 3 mM-ethanol, we observed no change in either the Km or Vmax. for aniline hydroxylation with the same concentration of ethanol (see Fig. 3 ). Although higher concentrations ofethanol did inhibit hydroxylation of aniline, the inhibition was complex, in that both Vmax. and Km were changed.
Since various drug oxidations were affected only in the presence of high concentrations of ethanol and since the inhibition observed was not usually competitive, it seems unreasonable to assert that ethanol is acting as an alternative substrate of the monooxygenase system. Therefore, another explanation for the inhibition of drug oxidations by high ethanol concentrations is required. We propose that the ethanol-induced inhibition is due to interference by ethanol with the binding of substrate by cytochrome P-450. This is based on the decrease in the magnitude of the hexobarbital-induced type I spectral change in the presence of high concentrations of ethanol, and the increased magnitude of the hexobarbital-induced spectral change, coupled with the decreased magnitude of the ethanol-induced reverse type I spectral change, after ethanol washing of the microsomal fraction. This would in turn imply that the reverse type I spectral change is caused by removal of added or endogenously bound substrate from cytochrome P450. Evidence for the presence of endogenously bound substrate of the mono-oxygenase system, even after washing of the microsomal fraction, has been reported by Diehl et al. (1970) and Orrenius et al. (1973) .
Hence, ethanol does not appear to bind to cytochrome P-450, as has been previously suggested by Lineweaver-Burk plots of ethanol interaction with rat liver microsomalfraction Nine different microsomal fractions were prepared as described in the Materials and Methods section. The microsomal suspensions contained 0.05M-TrisHCl buffer, pH7.5, and 1.9-2.6mg of protein/ml. Curve A, non-linear curve, obtained with five preparations. Curve B, linear curve obtained with four preparations. Rubin etal. (1971) , who based their conclusion in part on the linearity of the double-reciprocal plots of spectral change versus ethanol concentration. As shown in Fig. 7 , we also obtained linearity, but only in four of nine different microsomal preparations (curve B); the other five preparations produced a nonlinear curve, which was concave upward (curve A). This difference could be attributed to differences in amounts of endogenous substrate bound to cytochrome P-450 at the time of preparation of the microsomal fraction. Therefore, the shape ofthe curve as well as the magnitude of the reverse type I spectral change would be dependent on the amount of substrate-bound cytochrome P-450 present. This interpretation would also be compatible with the observations of an increased magnitude of the ethanolproduced reverse type I spectral change in microsomal fractions from ethanol-treated rats (Rubin et al., 1971) , since chronic ethanol administration is known to increase the content of liver cytochrome P-450 and thus probably also of endogenously substrate-bound cytochrome P-450.
